Ardent Health Partners (NYSE:ARDT) Stock Price Up 6.7% – Time to Buy?

Ardent Health Partners, LLC (NYSE:ARDT)’s stock price traded up 6.7% on Monday . The stock traded as high as $14.97 and last traded at $15.20. Approximately 53,937 shares changed hands during trading, a decline of 86% from the average daily volume of 379,756 shares. The stock had previously closed at $14.25.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on ARDT shares. Royal Bank of Canada reiterated an “outperform” rating and set a $23.00 price target on shares of Ardent Health Partners in a report on Thursday, November 14th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price objective on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Truist Financial lowered their price target on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Leerink Partners raised their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 12th. Finally, Bank of America lowered Ardent Health Partners from a “buy” rating to a “neutral” rating and cut their target price for the company from $22.00 to $19.00 in a research note on Wednesday, November 6th. Two research analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $21.55.

Ardent Health Partners Stock Up 6.8 %

The firm has a fifty day moving average of $16.01. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78.

Ardent Health Partners (NYSE:ARDT) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.19 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.10). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.46 billion. Research analysts anticipate that Ardent Health Partners, LLC will post 1.22 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Ardent Health Partners

Hedge funds and other institutional investors have recently made changes to their positions in the company. State Street Corp acquired a new position in shares of Ardent Health Partners during the third quarter worth about $1,977,000. Jane Street Group LLC acquired a new position in Ardent Health Partners during the third quarter worth $567,000. Allspring Global Investments Holdings LLC acquired a new stake in Ardent Health Partners in the 3rd quarter valued at $13,119,000. Goldentree Asset Management LP acquired a new stake in Ardent Health Partners in the 3rd quarter valued at $22,897,000. Finally, Barclays PLC bought a new stake in Ardent Health Partners during the 3rd quarter worth about $385,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.